An extra boost for U.S. seniors

VaxAmerica is pleased to offer Fluzone High-Dose flu vaccine, a vaccine developed specifically for people aged 65 and older.

Approved by the CDC’s Advisory Committee on Immunization Practices (ACIP), Fluzone High-Dose is proven to increase antibody levels by 80% - giving adults 65 years of age and older a stronger immune response and greater protection against the influenza (flu) virus.

For more information on the Fluzone High-Dose vaccine, please visit the CDC’s webpage here:
http://www.cdc.gov/flu/protect/vaccine/qa_fluzone.htm